126 results
Page 4 of 7
8-K
EX-99.1
dholohn 05a5c
9 May 22
VBI Vaccines Reports First Quarter 2022 Financial Results and Provides Corporate Update
8:00am
8-K
EX-99.1
ezl2omxuh
2 May 22
VBI Vaccines Announces European Commission Marketing Authorisation for PreHevbri™, a 3-Antigen Adult Hepatitis B Vaccine
8:00am
8-K
EX-99.1
rjrt7jg8gy
5 Apr 22
VBI Vaccines Announces New Data and Progress of VBI-2900, VBI’s eVLP Coronavirus Program
8:00am
8-K
EX-99.1
4vqc2xm8zxhp36fd qu
29 Mar 22
VBI Vaccines Announces PreHevbrio™ is Now Available in the United States for the Prevention of Hepatitis B in Adults
8:00am
8-K
EX-99.1
u9cq0
15 Mar 22
VBI Vaccines to Participate in the 32nd Annual Oppenheimer Healthcare Conference
8:00am
8-K
EX-99.1
m3tkv x1c7
7 Mar 22
VBI Vaccines Reports Fourth Quarter and Full Year Financial Results for 2021, Provides Corporate Update and Outlook for 2022
8:00am
8-K
EX-99.1
h8hz2u32 pcn
25 Feb 22
Regulation FD Disclosure
8:57am
8-K
EX-99.1
2s9g9yzrkdj s9
23 Feb 22
Regulation FD Disclosure
4:05pm
8-K
EX-99.1
9zfymayt
26 Jan 22
VBI Vaccines to Participate in the B. Riley Securities 2022 Oncology Investor Conference
8:00am
8-K
EX-99.1
o9yckjox0b5
5 Jan 22
Regulation FD Disclosure
8:00am
8-K
EX-99.1
r9ywnk 4apdsfabuq
9 Dec 21
VBI Vaccines Announces Filing of New Drug Submission for 3-Antigen Hepatitis B Vaccine to Health Canada
8:00am
8-K
EX-99.1
8fplw
1 Dec 21
VBI Vaccines to Present New Overall Survival Data from Phase 2a Study in Recurrent GBM at the World Vaccine & Immunotherapy Congress 2021
4:15pm
8-K
EX-99.1
0a3qm
1 Dec 21
VBI Vaccines Announces FDA Approval of PreHevbrio™ for the Prevention of Hepatitis B in Adults
7:30am
8-K
EX-99.1
wzgqgfue5t7s p8
16 Nov 21
VBI Vaccines to Participate in Jefferies London Healthcare Conference
8:00am
8-K
EX-99.1
ct3a2s9iplr 119biu8p
8 Nov 21
VBI Vaccines Announces Third Quarter 2021 Financial Results and Provides
8:00am
8-K
EX-99.1
pefewz hiaazqsefd62
1 Nov 21
VBI Vaccines Announces e-Poster Presentation of 3-Antigen Prophylactic
8:04am
8-K
EX-99.1
b4y2t0oit3fwzv07b
13 Oct 21
Regulation FD Disclosure
8:00am
8-K
EX-99.1
f3t68p6ehliw5h1 xgv
4 Oct 21
VBI Vaccines to Participate in Upcoming Investor Conferences
8:00am